Buy Divis Laboratories: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "Divis Laboratories had a sharp correction. After that correction it went into a trading range and that is good news because it was building a small base. It has broken out of that base while giving a bullish head and shoulder pattern. This is a reversal."

"It is also one of the few pharma stocks where there is potential for reaching its earlier highs and then beginning a new high process later on. So Divis Laboratories is a very attractive buying opportunity for today and also for the next few days," he said. The share touched its 52-week high Rs 1,233.00 and 52-week low Rs 927.00 on 30 November, 2012 and 10 June, 2013, respectively. Currently, it is trading 17.15 percent below its 52-week high and 10.19 percent above its 52-week low. Market capitalisation stands at Rs 13,558.81 crore.